Brain Disease Modalities And Software Market Key Players Analysis - Vuno Co., Ltd., Fujifilm Holdings Corporation, Aspect Imaging, IXICO, QMENTA.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Disease Modalities And Software Market Size, Share & Trends Analysis Report By Product (Brain Imaging Modalities and Brain Analysis Software), By Type of Patients (Adults, Pediatrics and Infants), Region, Market Outlook And Industry Analysis 2031"

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1945

According to the latest research by InsightAce Analytic, the Global Brain Disease Modalities And Software Market is valued at US$ 13.51 Billion in 2022, and it is estimated to reach US$ 21.12 Billion by 2031, with a CAGR of 5.23 % during the forecast period of 2023-2031.

Brain disease diagnostic modalities include conventional imaging techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, Positron Emission Tomography (PET) scans, as well as hybrid imaging systems that integrate PET with MRI or CT. CT imaging utilizes multi-angular, cross-sectional X-ray images through tomography and digital geometry, while MRI employs radio waves and magnetic fields to produce highly detailed images. These technologies are instrumental in diagnosing and monitoring a variety of neurological conditions, including neural activity, cerebral oxygenation, strokes, tumors, blood pressure abnormalities, traumatic brain injuries, and other critical brain functions.

Brain imaging software plays a pivotal role in enhancing diagnostic accuracy by providing quantitative analysis of images generated by these modalities. The software delivers comprehensive statistical data, enabling deeper insights into brain structures, biomarkers, and subtle anomalies, thereby facilitating more precise diagnosis of neurological disorders.

Market growth is primarily driven by technological advancements, notably the incorporation of artificial intelligence, alongside the rising incidence of neurological diseases and increased demand for safer, non-invasive imaging techniques. Although neuroimaging services experienced a temporary decline during the COVID-19 pandemic, this was partially counterbalanced by increased demand for respiratory imaging. Furthermore, the shortage of helium gas, which is vital for the operation of certain imaging devices, has affected device performance and availability. The substantial costs associated with imaging equipment and procedures remain a significant barrier, often prompting patients to explore alternative diagnostic options.

Regionally, North America and Europe dominated the brain disease diagnostic modalities and software market in 2022. However, the Asia-Pacific region is anticipated to register the highest compound annual growth rate (CAGR) during the forecast period, driven by technological advancements, expanding applications, and growing end-user demand.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01

Competitive Landscape
Some of The Key Players in The Brain disease modalities and software Market:
• Quantib
• Brainomix
• Qure.AI
• General Electric Company
• Imaging Biometrics, LLC
• United Imaging Healthcare Co. Ltd.
• Siemens
• Healthineers AG
• Koninklijke Philips N.V.
• Canon Inc.
• Vuno Co. Ltd.
• Aspect Imaging
• IXICO
• QMENTA
• Cortechs.ai
• A.I. Analysis Inc.
• Fujifilm Holdings Corporation
• Other Prominent Players.

Key developments
• In Mar 2023, Brainomix declared that the FDA had approved its Brainomix 360 e-ASPECTS tool for stroke, allowing the Oxford-based business to introduce its cutting-edge stroke AI imaging technology to US stroke facilities.
• In Jan 2022, Quantib introduced a substantial upgrade to its AI-powered solution for brain atrophy and white matter hyperintensity progression called Quantib® ND 2.0. This upgrade was made possible by the company's commitment to continuous research and development. The solution has been given authorization by the FDA for use in clinical settings in the United States.
• In Nov 2021, Siemens Healthineers Launches World's First CT Scanner 'NAEOTOM Alpha' With Photon-Counting Technology. The photon-counting technology enables drastic improvements in radiation dose by up to 45 percent rise in reduction and resolution for ultra-high resolution (UHR) scans compared with traditional CT detectors.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1945

Market Segments
Global Brain disease modalities and software Market segmented by Products, 2023-2031 (Value US$ Mn)
• Brain analysis software
 PET Devices
 CT Devices
 MRI Devices
 PET-CT
 PET-MRI
• Brain imaging modalities
Global Brain disease modalities and software Market segmented by Type of Patients, 2023-2031 (Value US$ Mn)
• Adults
• Pediatrics
• Infants
Global Brain disease modalities and software Market segmented by End-User, 2023-2031 (Value US$ Mn)
• Hospitals and clinics
• Ambulatory surgery centers
• Diagnostic imaging centers
Global Brain disease modalities and software Market segmented by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global protein design and engineering market
 To receive an industry overview and future trends of the protein design and engineering market
 To analyze the protein design and engineering market drivers and challenges
 To get information on the protein design and engineering market size (Value US$ Mn) forecast to 2031
 Significant investments, mergers & acquisitions in the protein design and engineering market industry

Read Overview Report- https://www.insightaceanalytic.com/report/brain-disease-modalities-and-software-market/1945

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.